Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
07/2011
07/27/2011EP2346879A1 A process for the preparation of s-clopidogrel
07/27/2011EP2346878A1 Fused pyridine derivatives as kinase inhibitors
07/27/2011EP2346862A1 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
07/27/2011EP2346859A1 Heterocyclic jak kinase inhibitors
07/27/2011CN102137831A Compound for organic thin film transistor and organic thin film transistor using same
07/27/2011CN102137830A Compound for organic thin-film transistor and organic thin-film transistor using same
07/27/2011CN102134249A Preparation method of chiral 5-protection-2-thia-5-aza-bicyclic (2.2.1) hepta-3-ketone
07/27/2011CN102134248A Multi-sulfo-disulfide alkene nickel coordination compound and preparation method and application thereof
07/27/2011CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use
07/27/2011CN101087795B Pharmaceutical compounds
07/26/2011US7985864 Organic dye used in dye-sensitized solar cell
07/26/2011US7985769 Compounds and methods for the treatment or prevention of Flavivirus infections
07/26/2011US7985768 Compounds as cannabinoid receptor ligands
07/26/2011US7985730 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/21/2011WO2011086321A1 Method for preparing polybiotinylated compounds
07/21/2011WO2011042804A3 An improved process for the preparation of clopidogrel hydrogen sulfate form i
07/21/2011WO2011027988A3 Novel polymorphic form of prasugrel-hydrogen sulfate
07/21/2011US20110178069 Inhibitors of interleukin-1 beta converting enzyme
07/21/2011US20110178068 Quaternary Ammonium Salt Prodrugs
07/21/2011US20110178055 Dual nk1/nk3 receptor antagonists
07/21/2011US20110177619 In vitro diagnostic markers comprising carbon nanoparticles and kits
07/21/2011US20110177493 Using highly sensitive suspended carbon nanotubes for molecular-level sensing based on optical detection
07/21/2011US20110177007 Dithienopyrrole Dyes for Imaging and Therapy
07/20/2011EP2344453A2 Activators of human pyruvate kinase
07/20/2011EP1730153B1 Isopropanol water solvate of olanzapine
07/20/2011EP1451195B1 3-biphenyl-substituted-3-substituted-4-ketolactams and ketolactones and their utilization as pesticide
07/20/2011CN102127210A Benzodithiophene based materials compositions
07/20/2011CN102127091A Heterocyclic ring-containing schiff base compound
07/20/2011CN101585842B Research and control method of impurity B control method in clopidogrel
07/20/2011CN101284837B Stereoselective total synthesis method of (+)-biotin
07/19/2011US7982055 Heterocyclic fused selenophene monomers
07/19/2011US7982040 Thienopyridinone compounds and methods of treatment
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/19/2011US7981884 Process for the preparation of olanzapine
07/19/2011CA2586011C Tricyclic pyrazole derivatives as cannabinoid receptor modulators
07/19/2011CA2237590C Cyclic and heterocyclic n-substituted .alpha.-iminohydroxamic and -carboxylic acids
07/14/2011WO2011083955A2 Method for manufacturing crystalline form (i) of clopidogrel hydrogen sulphate
07/14/2011WO2011051976A3 Process for the preparation of clopidogrel bisulfate form i
07/14/2011US20110172249 Method for improving absorbability of preparation, and preparation having improved absorbability
07/14/2011US20110172191 Thieno-pyridine derivatives as mek inhibitors
07/14/2011US20110171678 Modified carbocyanine dyes and their conjugates
07/13/2011EP2343302A1 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
07/13/2011EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof
07/13/2011EP2343290A1 Diamine derivatives as factor X inhibitors
07/13/2011EP2343058A2 A pharmaceutical formulation containing olanzapine
07/13/2011EP1931683B1 Fused tricyclic mglur1 antagonists as therapeutic agents
07/13/2011EP1854791B1 Novel thiophene compound and process for producing caffenofuran or analogue thereof from the same
07/13/2011EP1852434B1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
07/13/2011EP1802632B1 Thieno-pyrimidine compounds having fungicidal activity
07/13/2011EP1697327B1 Insecticidal spiroindane derivatives
07/13/2011EP1578741B1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
07/13/2011EP1539717B1 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
07/13/2011CN1867562B Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
07/13/2011CN102124011A Inhibitors of human immunodeficiency virus replication
07/13/2011CN102123990A Heterocyclic compound and use thereof
07/13/2011CN102120746A Clopidogrel hydrochloride crystal form II as well as preparation method and application thereof
07/13/2011CN102120745A Crystal form I of clopidogrel hydrochloride and preparation method and application thereof
07/13/2011CN102120744A Optical-activity 2-hydroxytetrahydrothienopyridine derivative, preparation method and application thereof in pharmacy
07/12/2011US7977466 C-glycoside derivatives and salts thereof
07/12/2011US7977374 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
07/12/2011US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
07/12/2011CA2577879C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon.
07/12/2011CA2517629C Phthalazinone derivatives
07/12/2011CA2431617C 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
07/07/2011WO2011081174A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
07/07/2011WO2011080445A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/07/2011WO2011080444A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/07/2011WO2011080277A1 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof
07/07/2011WO2011079407A1 New compounds having potency to inhibit blood clotting
07/07/2011WO2011057593A3 Salts of prasugrel and a method of their production
07/07/2011US20110166362 Novel compound and organic semiconductor material
07/07/2011US20110166354 Method for producing optically active amino acid derivative
07/07/2011US20110166307 Fused thiophenes, articles, and methods thereof
07/07/2011US20110166128 Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders
07/07/2011US20110166124 Tricyclic spirocycle derivatives and methods of use
07/07/2011US20110166116 New compounds, pharmaceutical composition and methods relating thereto
07/07/2011US20110165606 Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
07/07/2011US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof
07/07/2011US20110163302 Hole transport materials having a sulfur-containing group
07/07/2011CA2786089A1 Nitrogen-containing heterocyclic compound and agricultural fungicide
07/07/2011CA2784553A1 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof
07/07/2011CA2784153A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/07/2011CA2784152A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/06/2011EP2341051A1 Novel compound and organic semiconductor material
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011CN101198614B Thienopyrimidine derivative
07/05/2011US7973160 Nitrogen-containing aromatic derivatives
07/05/2011US7973159 Non-basic melanin concentrating hormone receptor-1 antagonists
07/05/2011US7973026 Thienopyrroles as antiviral agents
06/2011
06/30/2011WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same
06/30/2011WO2011077502A1 Dihydrothieno[2,3-e]indazole compound
06/30/2011WO2011077174A1 Process for preparing pharmaceutical compounds and intermediate compounds
06/30/2011WO2011077173A1 Improved process for preparing a pharmaceutical compound
06/30/2011WO2011075932A1 Induced layer material for preparing non-planar metal phthalocyanine weak epitaxy growth thin film
06/30/2011WO2011016686A3 Prasugrel disulfonate or crystalline forms thereof, method for preparing same, and pharmaceutical composition containing same
06/30/2011US20110160241 New peptidomimetic compounds
06/29/2011EP2338925A1 -electron conjugated compound, manufacturing method therefor, and -electron conjugated polymer obtained using same
06/29/2011EP1907397B1 Method of preparing clopidogrel and intermediates used therein
06/29/2011EP1907394B1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 214